LIMK2 and open-angle glaucoma: A dual inhibitor of LIMK2 and ROCK (LIMK2, IC50 7.5 nM), LX7101, has completed a Phase 1/2a study in primary open-angle glaucoma and ocular hypertension (NCT01528111) but the results are yet to be made available.